Darunavir Ethanolate – Anti-Retroviral / Anti-HIV Therapeutic

Darunavir Ethanolate – Anti-Retroviral / Anti-HIV Therapeutic

Darunavir Ethanolate CAS# 635728-49-3 is a second-generation protease inhibitor (PIs), designed specifically to overcome problems with the older agents in this class, such as indinavir. Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs. Darunavir is always used in combination with ritonavir (Norvir) and other anti-HIV medicines.

It is in our best interest to promote and to further your ongoing research and/or product development efforts. All the enumerated API’s are produced strictly following cGMP guidelines and regulations. It would be our pleasure to supply you with Darunavir Ethanolate, as well as any other new molecules that may be required.

Search Posts

Post Categories

Post Categories

Signup for our E-Newsletter

Email *

First Name *

Last Name *

Company *

Yes, I would like to receive emails from LGM Pharma. (You can unsubscribe anytime)

Constant Contact Use.

By submitting this form, you are consenting to receive marketing emails from: LGM Pharma, 2758 Circleport Dr., Erlanger, KY, 41018, http://lgmpharma.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact